


Healthcare News Roundup: Oncology
HSMN NewsFeed - 2 Feb 2011
Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
HSMN NewsFeed - 2 Feb 2011
Physicians in India Show Intense Interest in Arc-Based Radiation Therapy for Patients with Cancer
Physicians in India Show Intense Interest in Arc-Based Radiation Therapy for Patients with Cancer
HSMN NewsFeed - 31 Jan 2011
CyberKnife Radiosurgery to be Highlighted by Leading Thoracic Surgeons at 2011 STS Annual Meeting
CyberKnife Radiosurgery to be Highlighted by Leading Thoracic Surgeons at 2011 STS Annual Meeting
HSMN NewsFeed - 31 Jan 2011
Boston Scientific Announces FDA Approval of Renegade(R) HI-FLO Fathom(R) Pre-Loaded System
Boston Scientific Announces FDA Approval of Renegade(R) HI-FLO Fathom(R) Pre-Loaded System
HSMN NewsFeed - 27 Jan 2011
H3 Biomedicine Launches to Discover and Develop Next Generation Cancer Treatments
H3 Biomedicine Launches to Discover and Develop Next Generation Cancer Treatments
HSMN NewsFeed - 27 Jan 2011
Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab(R)
Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab(R)
HSMN NewsFeed - 26 Jan 2011
Calypso Medical Names Edward Vertatschitsch President and Chief Executive Officer
Calypso Medical Names Edward Vertatschitsch President and Chief Executive Officer
HSMN NewsFeed - 24 Jan 2011
Swedish Cancer Institute Installs First TomoTherapy(R) Radiation Therapy System in Seattle Metropolitan Area
Swedish Cancer Institute Installs First TomoTherapy(R) Radiation Therapy System in Seattle Metropolitan Area
HSMN NewsFeed - 19 Jan 2011
First Patients Complete Proton Therapy Treatment at CDH Proton Center, A ProCure Center
First Patients Complete Proton Therapy Treatment at CDH Proton Center, A ProCure Center
HSMN NewsFeed - 19 Jan 2011
Jennerex Names Ursula Fritsch, PharmD, as Vice President, Regulatory Affairs
Jennerex Names Ursula Fritsch, PharmD, as Vice President, Regulatory Affairs
HSMN NewsFeed - 18 Jan 2011
GE Healthcare Named Exclusive Distributor of Veran ig4 Navigation Systems in United States
GE Healthcare Named Exclusive Distributor of Veran ig4 Navigation Systems in United States
HSMN NewsFeed - 18 Jan 2011
ImmunoGen, Inc. Appoints Theresa Wingrove, Ph.D., as Vice President, Regulatory Affairs
ImmunoGen, Inc. Appoints Theresa Wingrove, Ph.D., as Vice President, Regulatory Affairs
HSMN NewsFeed - 18 Jan 2011
BSD Medical Reports First European Sale of MicroThermX Microwave Ablation System to Med-Italia Biomedica
BSD Medical Reports First European Sale of MicroThermX Microwave Ablation System to Med-Italia Biomedica
HSMN NewsFeed - 11 Jan 2011
First Five-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer
First Five-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer
HSMN NewsFeed - 10 Jan 2011
Varian Medical Systems Receives 510(k) Clearance for its Proton Therapy System
Varian Medical Systems Receives 510(k) Clearance for its Proton Therapy System
HSMN NewsFeed - 10 Jan 2011
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
HSMN NewsFeed - 5 Jan 2011
Melanoma, Ovarian, and Prostate Cancer Treatment Guidelines for Patients Available from NCCN
Melanoma, Ovarian, and Prostate Cancer Treatment Guidelines for Patients Available from NCCN
HSMN NewsFeed - 5 Jan 2011
U.S. Food and Drug Administration (FDA) Clears Novel ImageSense(TM) Technology for Use with Colposcopy
U.S. Food and Drug Administration (FDA) Clears Novel ImageSense(TM) Technology for Use with Colposcopy
HSMN NewsFeed - 22 Dec 2010
Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System
Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System
HSMN NewsFeed - 20 Dec 2010
Myriad Genetics Launches PANEXIA, New Predictive Test for Hereditary Pancreatic and Related Cancers
Myriad Genetics Launches PANEXIA, New Predictive Test for Hereditary Pancreatic and Related Cancers
HSMN NewsFeed - 15 Dec 2010
Accuray Receives FDA Clearance for the CyberKnife(R) System's Lung Optimized Treatment
Accuray Receives FDA Clearance for the CyberKnife(R) System's Lung Optimized Treatment
HSMN NewsFeed - 15 Dec 2010
EpiCept Announces Initiation by NCI of Phase II Trial with Crolibulin(TM) in Anaplastic Thyroid Cancer
EpiCept Announces Initiation by NCI of Phase II Trial with Crolibulin(TM) in Anaplastic Thyroid Cancer
HSMN NewsFeed - 13 Dec 2010
XGEVA (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
XGEVA (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
